Novo Nordisk disclosed a cybersecurity incident that involved unauthorized access to a limited number of internal IT systems containing personal data from clinical trial participants and healthcare providers. The company said the exposed information did not include direct identifiers, and no known cybercrime group has claimed responsibility. #NovoNordisk #Ozempic #Wegovy #Rybelsus #Victoza #Saxenda
Keypoints
- Novo Nordisk reported unauthorized access to a limited number of internal IT systems.
- The incident affected personal data tied to some clinical trial participants.
- Exposed data included patient IDs, trial participation details, biomarkers, and lifestyle factors.
- Healthcare providers’ contact and workplace information may also have been compromised.
- No threat actor has publicly claimed responsibility for the attack.
Read More: https://www.securityweek.com/ozempic-maker-novo-nordisk-says-hackers-breached-it-systems/